|
||||||||||||||||||
![]() |
||||||||||||||||||
|
||||||||||||||||||
|
![]() The Fungitell® assay measures levels of (1,3)-ß-D-glucan in serum. The detection reagent is a biological cascade based upon modified Limulus Amebocyte Lysate (LAL), an extract of the blood cells of the North American Horseshoe Crab. The assay is based upon a modification of the LAL pathway. The Fungitell reagent is modified to eliminate Factor C and, thus bypassing the activated factor B, to only react to (1,3)-ß-D-glucan, through the Factor G-mediated side of the pathway. This renders the reagent highly specific for (1,3)-ß-D-glucan and does not react to other polysaccharides, including beta-glucans with different glycosidic linkages. Enzyme Cascade: Similar to enzyme immunoassays, the Fungitell assay is performed in microplates and read in an incubating reader. It is a homogeneous assay, and does not require any washing steps. It can be completed in approximately one hour. In May, 2004, the FDA cleared the Fungitell kit for marketing, to assist in the diagnosis of fungal infections. Back To Top
Common primary human fungal pathogens are Candida spp. and Aspergillus spp., opportunistic fungal pathogens, including Fusarium spp., Trichosporon spp., Saccharomyces cerevisiae, Acremonium, Coccidioides immitis, Histoplasma capsulatum, Sporothrix schenckii, Blastomyces dermatitidis and Pneumocystis carinii. The (1,3)-ß-D-glucan produced by these organisms can be detected by the Fungitell assay. Normal human serum contains low levels of (1,3)-ß-D-glucan, typically 10-40 pg/mL, presumably from commensal yeasts present in the alimentary canal and gastrointestinal tract. Most pathogenic fungi have (1,3)-ß-D-glucan in their cell walls and minute quantities are sloughed into the circulation during the life cycle. Thus, (1,3)-ß-D-glucan appears in the serum in cases of invasive fungal infection (IFI). Monitoring serum glucanemia for evidence of elevated and rising levels provides a convenient surrogate marker for IFI. Levels above 80 pg/mL, in at-risk patients, are considered positive. The Fungitell assay is indicated for presumptive diagnosis of fungal infection. It should be used in conjunction with other diagnostic procedures. The Fungitell assay does not detect certain fungal species such as the genus Cryptococcus, which produces very low levels of (1,3)-ß-D-glucan. This assay also does not detect the Zygomycetes, such as Absidia, Mucor, and Rhizopus, which are not known to produce (1,3)-ß-D-glucan.
Patient
Samples Serum is the only sample type that is currently approved for use with the Fungitell assay. Serum that is hemolyzed, lipemic, or visually icteric or turbid is not suitable for use with the Fungitell assay. Because a fungal infection is a dynamic process repeat testing, typically 2-3 times per week, improves sensitivity. Time courses of serum (1,3)-ß-D-glucan levels through the course of an infection have been shown to exhibit a rising level which falls in response to efficacious therapy.
The Fungitell assay is indicated for presumptive diagnosis of fungal infection. It should be used in conjunction with other diagnostic procedures. The Fungitell assay does not detect certain fungal species such as the genus Cryptococcus, which produces very low levels of (1,3)-ß-D-glucan. This assay also does not detect the Zygomycetes, such as Absidia, Mucor, and Rhizopus, which are not known to produce (1,3)-ß-D-glucan. Back To Top |
|
||||||||||||||||
|
|
||||||||||||||||||